Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Minkoff

Showing results (221-230 of 306) with videos related to

Pageof 31
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 18, 2010
Marijuana use is not associated with cervical human papillomavirus natural history or cervical neoplasia in HIV-seropositive or HIV-seronegative womenGypsyamber D'Souza, Joel M Palefsky, Ye Zhong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV StudyAlexandra M Levine, Eric C Seaberg, Nancy A Hessol, et al.
The American Journal of Pathology|January 12, 2002
Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV statusAkiko Kobayashi, Teresa Darragh, Brian Herndier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2012
Responses to hepatitis A virus vaccine in HIV-infected women: effect of hormonal contraceptives and HIV disease characteristicsAdriana Weinberg, Amanda A Allshouse, Samantha Mawhinney, et al.
Infectious Diseases in Obstetrics and Gynecology|April 26, 2008
The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative womenHoward Minkoff, Ye Zhong, Howard D Strickler, et al.
AIDS (London, England)|November 27, 2013
Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected womenSanjiv M Baxi, Ruth M Greenblatt, Peter Bacchetti, et al.
Plos One|December 24, 2010
HIV tropism and decreased risk of breast cancerNancy A Hessol, Laura A Napolitano, Dawn Smith, et al.
The Journal of Infectious Diseases|December 16, 2003
Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative womenRaphael P Viscidi, Linda Ahdieh-Grant, Michael F Schneider, et al.
Journal of Women'S Health (2002)|June 27, 2006
Effects of HIV infection and its treatment on self-reported menstrual abnormalities in womenL Stewart Massad, Charlesnika T Evans, Howard Minkoff, et al.
American Journal of Obstetrics and Gynecology|April 25, 2003
Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virusSiobán D Harlow, Mardge Cohen, Suzanne E Ohmit, et al.
Pageof 31

Showing results (221-230 of 306) with videos related to

Sort By:
Pageof 31
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 18, 2010
Marijuana use is not associated with cervical human papillomavirus natural history or cervical neoplasia in HIV-seropositive or HIV-seronegative womenGypsyamber D'Souza, Joel M Palefsky, Ye Zhong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV StudyAlexandra M Levine, Eric C Seaberg, Nancy A Hessol, et al.
The American Journal of Pathology|January 12, 2002
Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV statusAkiko Kobayashi, Teresa Darragh, Brian Herndier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2012
Responses to hepatitis A virus vaccine in HIV-infected women: effect of hormonal contraceptives and HIV disease characteristicsAdriana Weinberg, Amanda A Allshouse, Samantha Mawhinney, et al.
Infectious Diseases in Obstetrics and Gynecology|April 26, 2008
The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative womenHoward Minkoff, Ye Zhong, Howard D Strickler, et al.
AIDS (London, England)|November 27, 2013
Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected womenSanjiv M Baxi, Ruth M Greenblatt, Peter Bacchetti, et al.
Plos One|December 24, 2010
HIV tropism and decreased risk of breast cancerNancy A Hessol, Laura A Napolitano, Dawn Smith, et al.
The Journal of Infectious Diseases|December 16, 2003
Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative womenRaphael P Viscidi, Linda Ahdieh-Grant, Michael F Schneider, et al.
Journal of Women'S Health (2002)|June 27, 2006
Effects of HIV infection and its treatment on self-reported menstrual abnormalities in womenL Stewart Massad, Charlesnika T Evans, Howard Minkoff, et al.
American Journal of Obstetrics and Gynecology|April 25, 2003
Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virusSiobán D Harlow, Mardge Cohen, Suzanne E Ohmit, et al.
Pageof 31